Healthcare / Medical Care FacilitiesHKSE
$0.41
+0.00 (+1.22%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 24% · confianza 25%
FCF escenarios
weak_data · normalized FCF $527.9M · quality 56.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
29/100
D
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$482M
P/E
N/A
•EV/EBITDA
1.3x
↓ROE
-9.3%
↓Gross Margin
80.7%
↑Debt/Equity
0.75
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+12.3%
FCF CAGR
+25.4%
FCF margin
16.6%
FCF / Net income
-4.10x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $4.14B · net income $-167.2M · FCF $686.1M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $4.14B | $4.14B | $4.21B | $3.88B | $2.92B |
| Net Income | $-167.2M | $-167.2M | $-18.9M | $69.7M | $197.5M |
| EBITDA | $619.3M | $619.3M | $743.3M | $786.6M | $802.7M |
| EPS | -0.14 | -0.14 | -0.02 | 0.06 | 0.17 |
| Gross Margin | 80.7% | 80.7% | 84.2% | 85.7% | 88.0% |
| Operating Margin | 2.3% | 2.3% | 4.4% | 4.9% | 13.4% |
| Net Margin | -4.0% | -4.0% | -0.4% | 1.8% | 6.8% |
| Balance Sheet | |||||
| Debt/Equity | 0.75 | 0.75 | 0.82 | 0.83 | 0.50 |
| Current Ratio | 0.87 | 0.87 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $686.1M | $686.1M | $527.9M | $192.8M | $348.1M |
| Returns | |||||
| ROE | -9.3% | -9.3% | -1.0% | 3.8% | 10.5% |
| Valuation | |||||
| P/E | — | — | — | 102.71 | 48.69 |
| EV/EBITDA | 1.33 | 1.33 | 3.52 | 10.17 | 12.05 |
| P/B | 0.27 | 0.27 | 0.80 | 3.87 | 5.10 |
| Growth & Yield | |||||
| Revenue Growth | -1.7% | -1.7% | 8.7% | 32.7% | — |
| EPS Growth | -781.2% | -781.2% | -127.1% | -64.9% | — |
| Dividend Yield | 1.8% | 1.8% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-30.2%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.02 → -0.14
Residual
-32.0%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.